Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody-associated vasculitis using the OMERACT process

Robson, Joanna C.; Milman, Nataliya; Tomasson, Gunnar; Dawson, Jill; Cronholm, Peter F.; Kellom, Katherine; Shea, Judy; Ashdown, Susan; Boers, Maarten; Boonen, Annelies; Casey, George C.; Farrar, John T.; Gebhart, Don; Krischer, Jeffrey; Lanier, Georgia; McAlear, Carol A.; Peck, Jacqueline; Sreih, Antoine G.; Tugwell, Peter S.; Luqmani, Raashid A.; Merkel, Peter A.

doi:10.3899/jrheum.141143

All Outputs (2)

Update on outcome measure development for large vessel vasculitis: Report from OMERACT 12 (2015)
Journal Article
Merkel, P. A., Mackie, S. L., Aydin, S. Z., Direskeneli, H., Sreih, A., Alibaz-Oner, F., …Kamali, P. A. M. (2015). Update on outcome measure development for large vessel vasculitis: Report from OMERACT 12. Journal of Rheumatology, 42(12), 2465-2469. https://doi.org/10.3899/jrheum.141144

© Copyright 2015 The Journal of Rheumatology. All rights reserved. Objective. The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided... Read More about Update on outcome measure development for large vessel vasculitis: Report from OMERACT 12.

Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody-associated vasculitis using the OMERACT process (2015)
Journal Article
Robson, J. C., Milman, N., Tomasson, G., Dawson, J., Cronholm, P. F., Kellom, K., …Merkel, P. A. (2015). Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody-associated vasculitis using the OMERACT process. Journal of Rheumatology, 42(11), 2204-2209. https://doi.org/10.3899/jrheum.141143

The Journal of Rheumatology Copyright © 2015. All rights reserved. Objective. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of linked multisystem life- and organ-threatening diseases. The Outcome Measures in Rheuma... Read More about Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody-associated vasculitis using the OMERACT process.